课题基金 / 基金详情

ANCILLARY STUDY TO THE HALT-C ANTI-VIRAL LONG-TERM TREATMENT AGAINST CIRRHOSI

ANCILLARY STUDY TO THE HALT-C ANTI-VIRAL LONG-TERM TREATMENT AGAINST CIRRHOSI
HALT-C 抗病毒长期治疗肝硬化的辅助研究
批准号:
7950902
负责人:
Mitchell L Shiffman
金额:
$0.05万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30

项目摘要

项目成果

Mitchell L Shiffman的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是建立一组慢性HEP-C患者,这些患者患有Ishak期3-6期纤维化,在聚乙二醇干扰素和利巴韦林联合治疗后经历持续的病毒学应答SVR,并获得临床结果和肝细胞癌的发生率以及与这些结果相关的因素。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of the study is to establish a cohort of chronic hep-C patients with Ishak stage 3-6 fibrosis who experienced a sustained virologic response SVR after peginterferon and ribavirin combination therapy and access the frequency of clinical outcomes and heptocellular carcinoma and factors associated with these outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANCILLARY STUDY TO THE HALT-C ANTI-VIRAL LONG-TERM TREATMENT AGAINST CIRRHOSI
  • 批准号:
    8166566
  • 项目类别:
  • 资助金额:
    $0.13万
  • 财政年份:
    2009
  • 负责人:
    Mitchell L Shiffman
  • 依托单位:
CLINICAL TRIAL: HEP C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C)
  • 批准号:
    7950846
  • 项目类别:
  • 资助金额:
    $19.64万
  • 财政年份:
    2008
  • 负责人:
    Mitchell L Shiffman
  • 依托单位:
QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION IN CHRONIC HEPATITIS C
  • 批准号:
    7717010
  • 项目类别:
  • 资助金额:
    $2.01万
  • 财政年份:
    2007
  • 负责人:
    Mitchell L Shiffman
  • 依托单位:
CLINICAL TRIAL: HEP C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C)
  • 批准号:
    7717009
  • 项目类别:
  • 资助金额:
    $21.35万
  • 财政年份:
    2007
  • 负责人:
    Mitchell L Shiffman
  • 依托单位:
海外基金